Subscribe to RSS - BioScrip


BioScrip sees growth in home infusion


ELMSFORD, N.Y. – BioScrip on March 2 reported revenues of $253.7 million for the fourth quarter of 2014, a 12.5% increase over the same period in 2013.

People and places: BioScrip, RemZzzs, Laboratory Tactical Consulting


Ryan McDevitt has joined Anna McDevitt at Laboratory Marketing. Ryan McDevitt will add business development consulting to the company’s brand development services.

BioScrip’s home infusion revenues jump nearly 50%


ELMSFORD, N.Y. – BioScrip has reported revenues of $247.1 million and a net loss of $18.6 million for the second quarter of 2014.

In brief: AAH to build audit tracker, BioScrip reports increase


WASHINGTON – AAHomecare plans to build a system to track the Medicare audits that are devastating HME providers, the association announced during its Washington Legislative Conference last week.

BioScrip reports double-digit increases


ELMSFORD, N.Y. – BioScrip reports revenue from continuing operations was $239.6 million in the first quarter of 2014, an increase of 32.3% over the same period last year.

In brief: Report cites spike in PAP use, Inogen sets IPO terms


WASHINGTON – The number of beneficiaries receiving PAP devices for a one-year time period grew 13%, while the total number of beneficiaries receiving all DMEPOS items during the same period fell 1%, according to a recently released comparative billing report.

BioScrip sells home health business


ELMSFORD, N.Y. – BioScrip plans to sell its home health business, Deaconess HomeCare, to LHC Group for $60 million in cash, the company announced Feb. 3.

In brief: CMS reports glitch, OIG reports overpayments


NASHVILLE, Tenn. – A problem with ordering/referring physician data in the DME MAC claim system is affecting processing, as well as the data available in the myCGS web portal and the Jurisdiction C IVR, according to a bulletin from CGS.

BioScrip to sell 6.8M shares in public offering


ELMSFORD, N.Y. – BioScrip, a provider of infusion and homecare services, has upped the ante on its public offering. The company announced Aug. 14 that it will offer 6,895,873 shares instead of 6,800,000, all of which are being sold by existing stockholders.

BioScrip obtains credit facility


ELMSFORD, N.Y. – BioScrip has secured a $75 million revolving credit facility, it announced today in a press release. A portion of it will be used toward the purchase of Cincinnati-based CarePoint Partners.